FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,400 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 8000 - 8200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2381Specimen from a Nonsterile Site (Specimen Type) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2382Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2383Absence of Skin Lesions (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2384Neuralgia (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2385Neuralgia (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2386Peripheral Nerve Thickening (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2387Nerve (Specimen Type) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2388Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.239Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.240Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2403NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2404Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2405Hepatitis D Virus Infection (Test for hepatitis D virus Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2406Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2407Firearm Injury (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2408Firearm Injury (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2409Babesiosis (Tests for B. microti IgG or Total Antibody [Titer])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2410Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2411Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2412Babesiosis (Tests for Babesia species IgG or Total Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2413Brucellosis (Tests for Brucella species IgG Antibody by ELISA)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2414Cranial Nerve Involvement (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2415Cranial Nerve Involvement (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2416Unusual Change in Behavior (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2417Radiculitis (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2418Subarachnoid Hemorrhage (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2419Subarachnoid Hemorrhage (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2420Discitis (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2421Discitis (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2423Respiratory Insufficiency [Unspecified Cause] (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2424Respiratory Insufficiency [Unspecified Cause] (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2425Conjunctival Suffusion (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2426Leptospira species (Tests by Microscopic Observation)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2427Leptospirosis (Tests for Leptospira Antibody by Agglutination)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2428Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2429Conjunctival Suffusion (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2430Pleural effusion (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2431Pleural effusion (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2432Abdominal swelling (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2433Abdominal swelling (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2434Neck swelling (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2435Neck swelling (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2436Diaphoresis (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2437Diaphoresis (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2438Edema (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2439Edema (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.244Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2440Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2441Anthrax (Tests for Bacillus species by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2442Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2443Influenza A (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2444Influenza B (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2445Influenza [Unspecified] (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2446Influenza A (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2447Influenza [Unspecified] (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2448Influenza (Tests for unspecified influenza virus Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2449Influenza (Tests for influenza B virus Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2450Influenza (Tests for unspecified influenza virus Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2451Influenza (Tests for influenza B virus Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2452Influenza (unspecified influenza virus in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2453Influenza (influenza B virus in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2454Influenza (Tests for unspecified influenza virus by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2455Influenza (Tests for influenza B virus by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2456Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2457Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2458Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2459Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2460Borrelia species (Tests by Microscopic Observation)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2461Borrelia species (Tests by Microscopic Observation in Blood)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2462Spirochetes (Tests by Microscopic Observation)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2463Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2464CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2465CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2466CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2467CRE (Tests for Enterobacterales species Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2468CRE (Combination Tests that include Enterobacterales by Culture and Identification)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2469Tests for Carbapenem Susceptibility [Meropenem and Doripenem]active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2470Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2471Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2473Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2474Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2475Aortic valve stenosis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2476Aortic valve stenosis (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2477Anotia (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2478Microtia (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2479Microtia (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2480Anotia (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2482Anophthalmia (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2483Anophthalmia (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2484Microphthalmia (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2485Microphthalmia (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2486Atrial septal defect (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2487Atrial septal defect (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2488Fetal Aortic valve stenosis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2489Congenital Posterior Urethral Valves (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2490Congenital Posterior Urethral Valves (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2491Bladder Exstrophy (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2492Bladder Exstrophy (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2493Encephalocele (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2494Fetal Encephalocele (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2495Encephalocele (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2496Choanal Atresia (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2497Choanal Atresia (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2498Cloacal Exstrophy (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2499Cloacal Exstrophy (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2500Renal Agenesis or Hypoplasia (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2501Renal Agenesis or Hypoplasia (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2502Trisomy 13 (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2503Trisomy 13 (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2504Fetal Trisomy 13 (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2505Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2506Galactosemia (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2507Galactosemia (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2508Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2509Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2510Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2511Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2512Galactosemia (Tests for Galactokinase (GALK) [Quantitative])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2513Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2514Galactosemia (Tests for GALT gene allele 1)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2515Galactosemia (Tests for GALT gene allele 2)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2516Hypospadias (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2517Hypospadias (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2518Trisomy 18 (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2519Fetal Trisomy 18 (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2520Fetal Trisomy 18 (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2521Trisomy 18 (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2522Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2523Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2524Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2525Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2526Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2527Chlamydia species [Unspecified] (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2528Ventricular septal defect (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2529Ventricular septal defect (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2530Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2531Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2532Congenital Cytomegalovirus (Tests for CMV Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2533Congenital Cytomegalovirus (Tests for CMV Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.268Mumps (Tests for mumps virus IgM Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.272Present or Positive Lab Result Valueactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.282Varicella (Tests for Varicella zoster virus by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.283Varicella (Tests for Varicella zoster virus Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.285Encephalitis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.287Varicella (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.289Carbon Monoxide Poisoning (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.293Toxic Effects of Lead (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.297Measles (Tests for measles virus Nucleic Acid)active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.299Measles (Tests for measles virus IgM Antibody)active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.300Meningococcal Disease (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.301Shigellosis (Tests for Shigella species by Culture and Identification Method)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.307Leptospirosis (Tests for Leptospira IgM Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.308Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.310Bacteria (Tests by Culture and Identification Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.311Viruses (Tests by Culture and Identification Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.316Rubella (Tests for rubella virus IgM Antibody)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.317Shigellosis (Tests for Shigella species Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.319Fungi (Tests by Culture and Identification Method)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.322Pesticide Related Illness (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.329Apnea (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.330Apnea (ICD10CM)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.333Shigellosis (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.335Influenza (Tests for influenza A virus by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.336Influenza (Tests for influenza A or B virus Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.340Influenza (influenza A or B virus in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.341Campylobacteriosis (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.342Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.343Campylobacteriosis (Tests for Campylobacter species Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.344Campylobacteriosis (Tests for Campylobacter species Antigen)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.349Hepatitis A (Tests for hepatitis A virus IgM Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.353Diarrhea (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.356HIV Infection (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.359Botulism (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.362Hansen’s Disease (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.365Silicosis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.366Silicosis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.371Cryptosporidiosis (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.372Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.375Cyclosporiasis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.376Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.379Giardiasis (Tests for Giardia species Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.384Listeriosis (Tests for Listeria monocytogenes Nucleic Acid)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.386Vibriosis (Organism or Substance in Lab Results)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.388Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.390Trichinellosis (Tests for Trichinella species Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.395Syphilis (Disorders) (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.396Syphilis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.398Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.399Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.40STEC Infection (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.400Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.401Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.403Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.405Hantavirus Infection and Diseases (Disorders) (ICD10CM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.407Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.408Hepatitis B Virus Infection (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.422Tuberculosis (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.427STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.43Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.436Coccidioidomycosis (Tests for Coccidioides species IgM Antibody)active2024-01hl7